Abstract
More than 30 years ago diabetic patients with end-stage renal disease (ESRD) were considered as inap-propriate candidates for a chronic dialysis programmebecause of a very high mortality rate and poor long-term survival w1x. In spite of this negative attitudeagainst diabetics on dialysis, not only more and morediabetic patients have been accepted to chronic renalreplacement therapy, but diabetes has become the mostcommon cause of ESRD, leading to renal replace-ment therapy in the western world w2x. Although theprognosis has improved markedly, mortality andmorbidity are still higher in diabetic compared tonon-diabetic patients undergoing haemodialysis (HD),peritoneal dialysis (PD), or after renal transplantation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
